Response Biomedical Corporation

Response Biomedical Corp. (“Response”) is a global company with an extensive Global Distribution Network. Response's Global Distribution Network has been and will continue to be a significant mainstay behind the continued growth and success of Response. The Response Corporate Office is located in Vancouver, Canada, with Regional Offices in Charlotte, NC, U.S.A. (Response Point of Care Inc.) and Shanghai, China that facilitate the true international reach of Response.

Mr. Adams is a Chartered Accountant with over 20 years of strategic financial management experience in both public and private companies. He was Chief Financial Officer of CellFor Inc., a privately held forestry biotechnology company that manufactures tree seedlings for international markets from August 2008 to 2012.

At Response Biomedical Corp. (“Response”), we believe that our greatest assets are our commitment to quality, continual improvement and the employees who ensure that we deliver the highest quality product to our customers. Response is dedicated to innovative and motivated employees who enthusiastically contribute to the growth of our company. Recently recognized as one of the 100 fastest growing companies in B.C., Response offers exciting opportunities and individual career growth for our employees.

Welcome to Response Biomedical Corp. (“Response”). Response is a proudly Canadian company that manufactures and distributes tests that aid in the diagnosis of serious medical conditions and potentially life-threatening environmental and biodefense dangers. Response tests provide fast results that aid healthcare professionals, first responders, biodefense personnel and environmental specialists in making fast, on-the-spot diagnoses that ultimately drive immediate, often life saving, medical treatment.

Mr. Tim Shannon has 25 years of experience in sales and marketing of medical devices and services. He has held senior management positions at successful companies ranging in size from pre-commercialization start-up endeavors to Fortune 50 companies.